ArticleCommunications medicine2024

Inhibiting anti-angiogenic VEGF165b activates a miR-17-20a-Calcipressin-3 pathway that revascularizes ischemic muscle in peripheral artery disease.

Sonia Batan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.